Patients in the EU with rare disease thymidine kinase 2 deficiency (TK2d) could be just weeks away from having the first ...
EMA committee recommends marketing approval for UCB’s Kygevvi to treat thymidine kinase 2 deficiency
EMA committee recommends marketing approval for UCB’s Kygevvi to treat thymidine kinase 2 deficiency: Brussels, Belgium Monday, February 2, 2026, 15:00 Hrs [IST] UCB, a global b ...
The £1.1m Rosetta Stone study hopes to make a breakthrough by comparing both conditions.
Fitgurú on MSN
The science of living longer: 5 essential workouts to boost your healthspan starting today
Modern fitness is shifting from looking good to living better, and research shows that specific training modalities are the ...
NEW YORK CITY, NY / ACCESS Newswire / February 1, 2026 / Peripheral neuropathy has become one of the fastest-growing quality-of-life challenges in 2026, especially among people living with diabetes, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results